Wednesday, February 24, 2021

COVID-19 updates: vaccine safety surveillance, policies to guide medical product developers addressing virus variants, Feb. 25 health equity webinar

COVID-19 response updates from FDA

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment